4 hours Amicus Therapeutics (NASDAQ:FOLD) Given New $15.00 Price Target at Bank of AmericaMarketBeat
Bank of America raised their target price on Amicus Therapeutics from $13.00 to $15.00 and gave the company a “buy” rating in a report on Thursday.
Bank of America (BAC) · Nasdaq 100
X